009420.KS
Hanall Biopharma Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 53,900.00
−2.00%Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- -KRW 368
- EPS estimate
- KRW 52
- Revenue actual
- KRW 44.3B
- Revenue estimate
- KRW 39.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -812.5%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jul 29, 2026